Skip to main content
. 2017 Nov 22;29(6):847–858. doi: 10.1007/s00192-017-3512-3

Table 3.

Primary and secondary outcomes at 7 years

Mesh Native tissue Risk difference (95% CI)
Primary outcome
Composite success overall
• Participants, n [% (95% CI)] 31/58 [53 (41, 66)] 37/69 [54 (42, 65)] −1 (−18, 17)
• Estimated % (95% CI) after MIa 53 (40, 66) 54 (43, 65) −1 (−18, 16)
• Estimated % (95% CI) after MIb 51 (38, 64) 50 (39, 61) −1 (−17, 16)
Change in composite success between 1 and 7 years
% (95% CI) of 7-year participant data −22 (−39, −5) −20 (−37, −4) 2 (−12, 16)
Composite failures 27/58 (47) 32/69 (46) 1 (−17, 18)
• Failure in treated compartment 3/58 (5) 18/69 (26) −21* (−33, −9)
• Failure in untreated compartment 17/58 (29) 5/69 (7) 22* (9, 35)
• Failure due to bulge but no POP > hymen 5/58 (9) 1/69 (1) 7 (−1, 15)
• Failure due to bulge (questionnaire only) 2/58 (3) 8/69 (12) −8 (−17, 1)
Secondary outcomes
Reoperation for POP 14c/56 (25) 11d/69 (16) 9 (−5, 23)
• In treated compartment 1 (7) 9 (82) −75* (−100, −48)
• In nontreated compartment 13 (93) 2 (18) 75* (48, 100)
POP ≥ stage II 28/53 (53) 47/67 (70) −17 (−35, 0)
Reoperation for POP and/or POP-Q ≥ stage II 35/56 (62) 53/69 (77) −15 (−30, 2)
POP > hymen 8/53 (15) 12/67 (18) −3 (−16, 10)
POP > hymen, no sensation of bulge 4/53 (8) 7/67 (10) −3 (−13,7)
Reoperation for POP and/or POP > hymen 22/58 (38) 23/69 (33) 5 (−12, 21)
Subjective outcomes
• Sensation of bulge 14/66 (21) 17/76 (22) −1 (−14,19)
• PGI-I (much to very much better) 42/60 (70) 41/72 (57) 13 (−3, 29)

Data presented as n (%), n [% (95% CI)], or % (95% CI)

POP pelvic organ prolapse, PGI-I Patient Global Impression of Improvement, MI multiple imputation of missing data,

a MI excluding deceased patients

b MI with failures for missings of deceased patients

c Nine patients received another mesh

d Nine patients received mesh

*This difference would be statistically significant if tested at a significance level of 0.05